Wall St. falls as Apple drags
tech shares lower
DJ: 21,235.67 -36.30 NAS: 6,175.46
-32.45 S&P: 2,429.39
-2.38 6/12
(Reuters) Apple shares added to last week's drop on
Monday to lead a market downturn as tech, still the best performing S&P 500
sector this year, succumbed under its own weight. Mizuho Securities cut its rating on Apple to
"neutral" from "buy" on Monday, saying the stock had
outperformed this year and that the "upcoming product cycle is fully
captured at current levels." Apple shares, down 2.4 percent on Monday, are
up about 26 percent so far in 2017.
The S&P technology sector fell 0.8 percent after
dropping 2.7 percent Friday for its largest two-day decline in nearly a year.
The tech-heavy Nasdaq Composite underperformed the S&P 500 as the ongoing
rout in the sector sparked a search for value elsewhere.
Energy stocks .SPNY, the worst performing sector
year-to-date, were among the ones trying to stop the bleeding on the S&P
500.
Despite the
flailing leadership in tech stocks, Brian Jacobsen, chief portfolio strategist at
Wells Fargo Funds Management in Menomonee Falls, Wisconsin, said he is not too
worried about it becoming a broader market selloff.
"We're not even in correction territory for the Nasdaq or large tech
shares. If economic data was worse than what it is, then I'd be
worried," he said.
"The risk of recession is still pretty low, so I think this (tech)
selloff is not a harbinger."
The Dow Jones
Industrial Average .DJI fell 36.3
points, or 0.17 percent, to 21,235.67, the S&P 500 .SPX lost 2.38
points, or 0.10 percent, to 2,429.39 and the Nasdaq Composite.IXIC dropped 32.45
points, or 0.52 percent, to 6,175.47.
Jacobsen said he would not yet buy into the market's
dip ahead of the Federal Reserve meeting that ends Wednesday, as the Fed is
"the biggest risk to the market" in the near-term.
"If the
Fed dismisses the recent bout of soft data and continues hiking (rates) for the sake of
hiking, then we could see
a correction" in the stock market, he said.
General Electric (GE.N) was the S&P's
biggest boost with a 3.6 percent advance to $28.94. Jeff Immelt will retire as
chief executive and would be replaced by John Flannery, the head of GE
healthcare, who said he will conduct a swift review of the business portfolio.
The largest percentage gainer on the S&P 500 was
Under Armour (UAA.N), which rose 5.8
percent, while the largest decliner was Netflix (NFLX.O), down 4.2
percent.
Coherus BioSciences (CHRS.O) tumbled 23.8
percent to $15.73 after the FDA denied the approval of its biosimilar for
Amgen's (AMGN.O) Neulasta. Amgen
edged up 0.5 percent to $164.88.
Advancing issues barely outnumbered declining ones
on the NYSE by a 1.03-to-1 ratio; on Nasdaq, a 1.37-to-1 ratio favored
decliners.
About 7.89 billion shares changed hands in U.S. exchanges, far above
the 6.81 billion daily average over the last 20 sessions.
No comments:
Post a Comment